T505-2694 Screening compound: N-(cyclopropylmethyl)-1-(2-{1-[3-(1H-indol-3-yl)propanoyl]piperidin-2-yl}ethyl)-1H-1,2,3-triazole-4-carboxamide

T505-2694 Screening compound: N-(cyclopropylmethyl)-1-(2-{1-[3-(1H-indol-3-yl)propanoyl]piperidin-2-yl}ethyl)-1H-1,2,3-triazole-4-carboxamide
T505-2694 Screening compound: N-(cyclopropylmethyl)-1-(2-{1-[3-(1H-indol-3-yl)propanoyl]piperidin-2-yl}ethyl)-1H-1,2,3-triazole-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound T505-2694
N-(cyclopropylmethyl)-1-(2-{1-[3-(1H-indol-3-yl)propanoyl]piperidin-2-yl}ethyl)-1H-1,2,3-triazole-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

T505-2694

Molecular Formula

C25H32N6O2 (C25 H32 N6 O2)

Compound Name

N-(cyclopropylmethyl)-1-(2-{1-[3-(1H-indol-3-yl)propanoyl]piperidin-2-yl}ethyl)-1H-1,2,3-triazole-4-carboxamide

IUPAC name

N-(cyclopropylmethyl)-1-(2-{1-[3-(1H-indol-3-yl)propanoyl]piperidin-2-yl}ethyl)-1H-123-triazole-4-carboxamide

SMILES

O=C(CCc1c[nH]c2c1cccc2)N1C(CCn2nnc(C(NCC3CC3)=O)c2)CCCC1

InChI

InChI=1S/C25H32N6O2/c32-24(11-10-19-16-26-22-7-2-1-6-21(19)22)31-13-4-3-5-20(31)12-14-30-17-23(28-29-30)25(33)27-15-18-8-9-18/h1-2,6-7,16-18,20,26H,3-5,8-15H2,(H,27,33)/t20-/m1/s1

InChI Key

NVRRWHYJRRZWJJ-HXUWFJFHSA-N

MDL Number (MFCD)

MFCD32262214

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

448.57

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.991

Distribution Coefficient, logD

2.991

Water Solubility, LogSw

-3.09

Polar Surface Area

77.304

Acid Dissociation Constant (pKa)

14.75

Base Dissociation Constant (pKb)

-0.32

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

52.00

T505-2694 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Protein-Protein Interaction Library (218420 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Antibacterial Compounds Library (13827 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics
Therapeutical areas:
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Infections
  • Immune system
  • animal

References: we are preparing a list of scientific research reports with T505-2694 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound T505-2694?
Check Price and Availability of T505-2694, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of T505-2694 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for T505-2694
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for T505-2694
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of T505-2694 available by request